General description
An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Vimpat is a registered trademark of Harris FRC Corporation
- UPC:
- 51471803
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- L-032-1ML